1 completed, 1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Small Cell Lung Cancer SCLC: new trials by email Literature Review of Small Cell Lung Cancer SCLC trials Research Report on Small Cell Lung Cancer SCLC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer Lung Cancer, Non-small Cell Lung Cancer NSCLC | Completed | Bristol-Myers Squibb | 6205 | 2017-12-07 | 2021-09-14 | |
| Study in Patients With SCLC of Veliparib in Combination With Topotecan veliparib, Topotecan - Small Cell Lung Cancer SCLC | Phase 1 | Unknown | Central European Society for Anticancer Drug Research | 30 | 2016-10-01 | 2021-01-27 |
Small Cell Lung Carcinoma (2) · Lung Neoplasms (1)
Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Lung Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Lung Neoplasms (1)
Poly(ADP-ribose) Polymerase Inhibitors (1) · Topotecan (1) · veliparib (1)
Bristol-Myers Squibb (1) · Central European Society for Anticancer Drug Research (1)
China (1) · Germany (1)